Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.61 |
| ▸ | HTT | P42858 | 2/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | TRPV1 | Q8NER1 | 5/20 | 0.59 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2276494 | 1.00 | ALDH1A1 (0.61) | ALDH1A1HTTMAPTTDP1TRPV1 | |
| SCHEMBL2275533 | 0.90 | TRPM2 (0.58) | ALDH1A1MAPTTDP1TRPM2SMN1; SMN2 | |
| SCHEMBL2275540 | 0.90 | TRPM2 (0.58) | ALDH1A1MAPTTDP1TRPM2SMN1; SMN2 | |
| SCHEMBL14428476 | 0.89 | TRPV1 (0.58) | ALDH1A1HTTMAPTTRPV1SMN1; SMN2 | |
| SCHEMBL2270176 | 0.86 | TRPA1 (0.60) | ALDH1A1MAPTTRPM2SMN1; SMN2MEN1 | |
| SCHEMBL2270181 | 0.86 | TRPA1 (0.60) | ALDH1A1MAPTTRPM2SMN1; SMN2MEN1 | |
| SCHEMBL6791019 | 0.85 | ALDH1A1 (0.80) | ALDH1A1HTTMAPTTDP1TRPV1 | |
| SCHEMBL6791025 | 0.85 | ALDH1A1 (0.80) | ALDH1A1HTTMAPTTDP1TRPV1 | |
| SCHEMBL2272147 | 0.85 | TRPM2 (0.77) | ALDH1A1HTTMAPTTDP1TRPV1 | |
| SCHEMBL2272146 | 0.85 | TRPM2 (0.77) | ALDH1A1HTTMAPTTDP1TRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7999132-B2 | Anthranilic acid derivative or salt thereof | TOYAMA CHEMICAL CO., LTD. (JP) | 2011-08-16 | — | — | US | disclosed |
| US-20090240052-A1 | NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF | TOYAMA CHEMICAL CO., LTD. (JP) | 2009-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090240052-A1 | NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF | MMP13, MMP26, MMP11 | ALDH1A1 645/4885HTT 3716/4885MAPT 4824/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.